Literature DB >> 16998135

Salivary LL-37 secretion in individuals with Down syndrome is normal.

G Bachrach1, G Chaushu, M Zigmond, E Yefenof, A Stabholz, J Shapira, J Merrick, S Chaushu.   

Abstract

Antimicrobial peptides play an important role in the innate immune response. Deficiency in salivary LL-37 antimicrobial peptide has been implicated in periodontitis in patients with morbus Kostman syndrome. Down syndrome is associated with periodontitis, diminished salivary flow, and salivary immunoglobulin deficiency. In the present study, levels of LL-37 and its hCAP18 precursor were measured in saliva samples from young individuals with Down syndrome and compared with levels in those from age-matched healthy controls. LL-37 and human cathelicidin antimicrobial protein (hCAP18) were detected in whole but not in parotid saliva. hCAP18 was more abundant than LL-37. The concentrations of salivary hCAP18 and LL-37 were found to be higher in individuals with Down syndrome than in healthy controls, but their secretion rates were similar. We concluded that, while the adaptive immunity of individuals with Down syndrome is impaired at the oral mucosa, the secretion rate of the LL-37 component of the innate immune system is normal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16998135     DOI: 10.1177/154405910608501012

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  12 in total

Review 1.  Antimicrobial peptides in periodontal innate defense.

Authors:  Sven-Ulrik Gorr
Journal:  Front Oral Biol       Date:  2011-11-11

2.  Human cathelicidin antimicrobial peptide LL-37 promotes lymphangiogenesis in lymphatic endothelial cells through the ERK and Akt signaling pathways.

Authors:  Takahiro Yanagisawa; Masakazu Ishii; Manami Takahashi; Kei Fujishima; Masahiro Nishimura
Journal:  Mol Biol Rep       Date:  2020-09-04       Impact factor: 2.316

3.  The antibacterial activity of LL-37 against Treponema denticola is dentilisin protease independent and facilitated by the major outer sheath protein virulence factor.

Authors:  Graciela Rosen; Michael N Sela; Gilad Bachrach
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

4.  LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations.

Authors:  Asaf Sol; Ofir Ginesin; Stella Chaushu; Laila Karra; Shunit Coppenhagen-Glazer; Isaac Ginsburg; Gilad Bachrach
Journal:  Infect Immun       Date:  2013-07-08       Impact factor: 3.441

5.  LL-37 disrupts the Kaposi's sarcoma-associated herpesvirus envelope and inhibits infection in oral epithelial cells.

Authors:  David C Brice; Zsolt Toth; Gill Diamond
Journal:  Antiviral Res       Date:  2018-08-02       Impact factor: 5.970

6.  Significant modifications of the salivary proteome potentially associated with complications of Down syndrome revealed by top-down proteomics.

Authors:  Tiziana Cabras; Elisabetta Pisano; Caterina Montaldo; Maria Rita Giuca; Federica Iavarone; Giuseppe Zampino; Massimo Castagnola; Irene Messana
Journal:  Mol Cell Proteomics       Date:  2013-03-26       Impact factor: 5.911

7.  Salivary antimicrobial peptides (LL-37 and alpha-defensins HNP1-3), antimicrobial and IgA responses to prolonged exercise.

Authors:  Glen Davison; Judith Allgrove; Michael Gleeson
Journal:  Eur J Appl Physiol       Date:  2009-03-05       Impact factor: 3.078

8.  Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.

Authors:  Michal Gutner; Stella Chaushu; Daniela Balter; Gilad Bachrach
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

Review 9.  Epithelial antimicrobial peptides: guardian of the oral cavity.

Authors:  Mayank Hans; Veenu Madaan Hans
Journal:  Int J Pept       Date:  2014-11-11

10.  Synergistic anti-inflammatory activity of the antimicrobial peptides human beta-defensin-3 (hBD-3) and cathelicidin (LL-37) in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts.

Authors:  Telma Blanca Lombardo Bedran; Márcia Pinto Alves Mayer; Denise Palomari Spolidorio; Daniel Grenier
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.